Home / Posts Tagged "doxorubicin"

Lupin Limited announced on Thursday the launch of its generic cancer treatment drug in the US market. The Mumbai-based pharmaceutical firm has introduced Doxorubicin Hydrochloride Liposome Injection in single-dose vials. This launch follows the approval from the US Food and Drug Administration (FDA) received by Lupin’s

READ MORE

The $4.20-billion pharmaceutical market of the Philippines accounts for a significant market for Venus Remedies from the ASEAN region as the company moves a step closer towards emerging as the top oncology medicine supplier from India in Southeast Asia  Venus Remedies’ oncology wing has

READ MORE